IC
ADMA icon

Ikarian Capital’s ADMA Biologics ADMA Stock Holding History

Ikarian Capital’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-234,854
Closed -$4.28M – 162
2025
Q4 		$4.28M Buy
234,854
+75,000
+47% +$1.26M 0.33% 69
2025
Q3 		$2.34M Buy
+159,854
New +$2.74M 0.24% 92
2020
Q4 		– Sell
-200,000
Closed -$478K – 231
2020
Q3 		$478K Sell
200,000
-178,574
-47% -$490K 0.03% 143
2020
Q2 		$1.11M Sell
378,574
-251,426
-40% -$722K 0.09% 120
2020
Q1 		$1.81M Buy
+630,000
New +$2.18M 0.14% 99

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return